Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 July 2022 | Story Lunga Luthuli

From an early age, many have been taught that strangers are not only a danger to the individual, but to the communities too.

A StrangerKind (ASK), an organisation hosting unconventional conversations in communities on topics and responding to questions that many may not have the opportunity to ask, has partnered with the University of the Free State to host the talks that aims to promote curiosity, diversity, and social cohesion.

As part of the ASKcampus – a first to be hosted at any university in the country – participants will have an opportunity to talk to a stranger in a safe setting and ask any question that comes to mind, without any judgement.

Michelle Nöthling, Assistant Researcher in Kovsie Support Services, said: “The ASK event is an opportunity for participants to pick a topic from a list that sparks curiosity and book an available 45-minute time slot. During your session, you sit down to a one-on-one conversation with a stranger who will briefly introduce themselves and their topic. They will then share their personal life experience on that topic with you.”

The event, which will be launched at the Thakaneng Bridge, Bloemfontein Campus, on 28 July 2022, is open to both UFS staff and students.

“During the individual sessions, participants may ask the strangers anything about the chosen topic. We even encourage you to ask those questions that you might otherwise have been too shy, or felt were too ignorant, to ask. What is more, is that the strangers you will meet will be fellow UFS staff and students. But you will not know who your stranger is until you sit down with them,” said Michelle.

Individuals who want to know more about becoming a UFS stranger are encouraged to visit the organisation’s YouTube channel or register to attend training and become a ‘stranger’.

Be curious. Be brave. Talk to strangers.

Launch details:
Date
: 28 July 2022
Time
: 10:00-14:00
Venue
: Thakaneng Bridge, Bloemfontein Campus

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept